Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2012

View Archived Issues

Health Canada approves line extension for Prevnar 13

Bioheart gains worldwide rights to adipose stem cell technology

Novel MAP kinase p38 alpha inhibitors synthesized at Amgen

BioCryst reports preclinical data on BCX-5191

Adeona Pharmaceuticals changes name

Arno Therapeutics and Invivis Pharmaceuticals sign licensing agreement

GSK withdraws indication extension application for Tyverb

German marketing collaboration signed for Vitaros

Novartis Vaccines and Diagnostics withdraws MAA for Fluad Pediatric

New aldose reductase inhibitors designed in U.S.

New GSNOR inhibitors and tachykinin NK3 receptor antagonists patented

Genetadi Biotech presents novel integrin alpha-V/beta-3 ligands

Takeda reports novel NF-kappa-B activation inhibitors

Japanese and Spanish university jointly develop new beta-amyloid production inhibitors

Novel candidate analgesics prepared at Pfizer

Chinese company divulges new GPR119 receptor agonists and DPP IV inhibitors

Collaborating U.S. universities identify new monoamine reuptake inhibitors

FDA accepts Uceris NDA

New beta-amyloid production inhibitors discovered at Bristol-Myers Squibb

UCB planning regulatory applications for Cimzia in new indication

Study reveals mode of action of influenza-inhibiting NME

New analgesic is potent and not addictive

BioMarin begins clinical testing of achondroplasia candidate

Ongoing phase III trials of NX-1207 show no safety concerns

Roche obtains Canadian approval for Zelboraf

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...